Company

Roche

Official Name: Roche Holding AG

Headquarters: Basel, Switzerland

Employees: 100,920

CEO: Dr. Severin Schwan Ph.D.

show_chart SIX: ROG -0.10%

Market Cap

CHF239.95 Billion

CHF as of Jan. 1, 2023

US$259.51 Billion

history Market Cap History

Roche market capitalization evolution

Evolution of Roche Holding AG market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Roche Holding AG

Detailed Description

Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro diagnostics solutions for indications, such as cardiology, hematology, blood donor screening, coagulation, infectious disease, gynecology, oncology, and women's health. In addition, the company supplies diagnostic instruments, reagents, consumables, and test kits for use in the diverse research market. It has collaboration with Gilead Sciences, Inc. for COVID-19; and a license and collaboration agreement with Shionogi & Co., Ltd. to develop and commercialize Xofluza. The company was founded in 1896 and is headquartered in Basel, Switzerland.

Stocks & Indices

Roche Holding AG has the following listings and related stock indices.


Stock: SIX: ROG

Stock: BMV: ROGN

Stock: OTC: RHHBF

Stock: OTC: RHHBY

Stock: OTC: RHHVF

Stock: SIX: RO

Stock: FSX: RHO6

Details

Headquarters:

Konzern Hauptsitz

Grenzacherstrasse 124

Basel, 4070

Switzerland

Phone: 41 61 688 11 11

Fax: 41 61 691 00 14